Astec Lifesciences has informed that the Board of Directors of the Company at its meeting held on May 04, 2016, has considered the recommendation of the Nomination and Remuneration Committee the Board of Directors has appointed Arijit Mukherjee as a Whole Time Director of the Company with immediate effect, subject to approval of Shareholders; Further, the Compensation Committee at its Meeting held May 04, 2016 has allotted 27,600 Equity Shares of Face Value Rs 10 each to the employees of the Company on exercise of Options granted to them, at an exercise price of Rs 34 per Equity Share, under Astec Employee Stock Options Plan, 2012, as fully paid-up. The above 27,600 Equity Shares would rank pari passu with the existing Equity Shares of the Company in all respects including dividend entitlement. With this allotment the total paid-up capital of the Company stands at Rs 194.826,550 (divided into 19,482,655 Equity Shares of Rs10 each).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| UPL | 665.00 |
| PI Industries | 3144.45 |
| Bayer CropScience | 4900.45 |
| Sharda Cropchem | 1109.70 |
| Sumitomo Chemical | 441.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: